Markets

Bernstein Initiates P&G Coverage with Market Perform, Cautious on Upside

Bernstein initiated coverage of Procter & Gamble with a Market Perform rating and $156 price target, suggesting limited upside from Friday's close of $149.61 as investors await Q4 earnings.

Daniel Marsh · · · 3 min read · 2 views
Bernstein Initiates P&G Coverage with Market Perform, Cautious on Upside
Mentioned in this article
PG $149.61 +0.86%

Shares of Procter & Gamble (PG) edged up 0.86% on Friday to close at $149.61, joining a broader market rally that saw the Dow climb 0.70% and the S&P 500 advance 0.50%. The stock inched higher in after-hours trading to $149.70. Defensive consumer staples like P&G benefited from the overall positive sentiment, but the session's gains were modest.

Bernstein's Cautious Outlook

Bernstein SocGen Group initiated coverage of P&G on Friday, assigning a Market Perform rating and a 12-month price target of $156. That target sits just 4% above the stock's closing price, signaling that the analyst sees limited upside potential in the near term. The firm's view is that P&G's recent bounce is more about valuation stabilization than a fundamental re-rating.

Bernstein expects low single-digit organic sales growth for P&G, excluding the effects of foreign exchange, acquisitions, and divestitures, with the Beauty segment as the primary growth driver. However, the analyst warns of increasing private-label pressure in the bathroom tissue category and heightened competition from smaller brands in the diaper market.

Recent Performance and Outlook

P&G has managed to hold its ground relative to many consumer peers. In its fiscal third quarter ended March 31, the company reported net sales of $21.2 billion, up 7% year over year. Organic sales rose 3%, while core earnings per share increased 3% to $1.59. The company returned $3.2 billion to shareholders through dividends and share buybacks during the quarter. CEO Shailesh Jejurikar described the results as a "solid acceleration in top-line results." P&G maintained its existing full-year guidance for sales, earnings, and cash returns.

The next major catalyst for the stock is the fiscal fourth-quarter 2026 earnings call, scheduled for July 29. Investors will be closely watching whether organic sales growth can be sustained and whether the company can protect margins amid rising costs. P&G has been pushing through price increases and pursuing productivity improvements to offset headwinds, but the numbers carry extra weight after the company flagged in April that after-tax commodity costs and tariffs are expected to weigh by $150 million and $400 million, respectively, with fiscal 2026 EPS now tracking at the low end of its target range.

Bull and Bear Cases

On the bullish side, P&G remains a resilient play in times of consumer spending uncertainty. The company's portfolio includes iconic brands such as Tide, Pampers, Gillette, Olay, Oral-B, and Vicks, and it operates in approximately 70 countries. P&G plans to allocate about $10 billion to dividends and nearly $5 billion to share buybacks in fiscal 2026. The company recently raised its quarterly dividend to $1.0885 per share, marking its 70th consecutive year of dividend increases.

The bearish argument centers on valuation. P&G shares trade at roughly 21.9 times earnings, which is not cheap by historical standards. Bernstein's cautious rating also points to competitive pressures and slower category growth that could cap gains even if the core business remains stable. The stock has not returned to its 52-week high of $167.25.

Market Context

At Friday's close, P&G appears fairly valued but not especially cheap. The stock continues to attract income-oriented investors with its dividend yield and buyback program, but the current valuation leaves little room for error. Any adverse developments related to tariffs, commodity costs, private-label competition, or softer consumer demand could pressure earnings. The July 29 earnings report will be the key focus as investors look for evidence that P&G can translate its defensive appeal into stronger share price performance.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →